SEC Form 4 · accession 0001144204-15-015476
DERMA SCIENCES, INC. · DSCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Caminis
Officer — Chief Medical Officer
Period of report
Mar 9, 2015
Accepted (ET)
Mar 11, 2015 · 8:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000892160
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1 | $7.51 | Mar 9, 2015 | A | 15,000 | A | Mar 9, 2016 | Mar 9, 2025 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The options were issued under the issuer's equity incentive plan and will vest as to 25% of the grant on the first, second, third and fourth anniversaries of the grant date so long as the reporting person remains an employee of the issuer.
- F2The options were granted under the issuer's equity incentive plan and without payment of consideration in connection with the reporting person's employment with the issuer.